Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluating Genes in Sputum to Measure Drug Response in COPD
This study has been terminated.
Study NCT00233051   Information provided by National Jewish Health

First Received on October 3, 2005.   Last Updated on July 19, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Emphysema
Chronic Bronchitis
Additional conditions recognized in this trial
Bronchitis
Bronchitis, Chronic
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Pulmonary Emphysema
Respiration Disorders
More general conditions related to this trial
Bronchial Diseases
Pathologic Processes
Respiratory Tract Diseases
Respiratory Tract Infections
Additional drug interventions recognized in this trial
Fluticasone
Salmeterol
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic beta-2 Receptor Agonists
Adrenergic beta-Agonists
Anti-Allergic Agents
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Autonomic Agents
Bronchodilator Agents
Dermatologic Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
National Jewish Health
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services